BANGALORE, Inde et HYDERABAD, Inde–(BUSINESS WIRE)–Pandorum Technologies, une société de médecine régénérative au stade clinique qui développe une plateforme de nouvelle génération pour la régénération tissulaire programmable, a annoncé aujourd’hui u…
Alcon, STAAR Surgical terminate merger agreement
Editor’s note: This is a developing news story. Please check back soon for updates.Alcon and STAAR Surgical terminated their definitive merger agreement.According to a press release from STAAR, preliminary estimates showed that the company did not rece…
Riassunto: Pandorum Technologies e Nucelion Therapeutics annunciano una collaborazione strategica imperniata sulla produzione di una terapia rigenerativa dei tessuti basata su esosomi mirata alle patologie oculari nei mercati APAC
BANGALORE, India, e HYDERABAD, India–(BUSINESS WIRE)–Pandorum Technologies, specialista della medicina rigenerativa in fase clinica impegnato nello sviluppo di una piattaforma di nuova generazione per la rigenerazione programmabile dei tessuti, oggi …
Resumen: Pandorum Technologies y Nucelion Therapeutics anuncian una colaboración estratégica para elaborar una terapia regenerativa de tejidos con base en exosomas para enfermedades oculares en mercados de APAC
BANGALORE (India) e HYDERABAD (India)–(BUSINESS WIRE)–Pandorum Technologies, una empresa de medicina regenerativa de fase clínica que está diseñando una plataforma de próxima generación para regeneración de tejidos programable, anunció hoy una colabo…
Alcon Terminates Agreement to Acquire STAAR Surgical
GENEVA–(BUSINESS WIRE)–Alcon Terminates Agreement to Acquire STAAR Surgical
National Vision Announces Participation in the 2026 ICR Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company is scheduled to present at the 2026 ICR Conference on Tuesday, January 13, 2026, at 9:00 a.m. Eastern Time….